We are live on ! Find out more
BDR

Blonder Tongue Laboratories Inc

Delisted

BDR was delisted on the 24th of June, 2022.

7 hedge funds and large institutions have $272K invested in Blonder Tongue Laboratories Inc in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more funds holding

Funds holding: 77 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

18% less capital invested

Capital invested by funds: $332K → $272K (-$60K)

Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BDR Hedge Fund Activity: Q1 2020 in Review

7 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q1 2020, worth a combined $272K — down 18% from $332K a quarter earlier.

Fund positioning in BDR was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $2.9K. The largest seller was Cambridge Trust, exiting entirely with an estimated $10K sold.

  • 7 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $272K of Blonder Tongue Laboratories Inc stock for Q1 2020, down 18% quarter-over-quarter.
  • 1 fund opened new Blonder Tongue Laboratories Inc positions in Q1 2020 and 1 closed out, a net change of 0 holders.
  • The largest Blonder Tongue Laboratories Inc buyer in Q1 2020 was UBS Group, an estimated $2.9K added.
  • The largest Blonder Tongue Laboratories Inc seller in Q1 2020 was Cambridge Trust, an estimated $10K sold.

Based on aggregated 13F filings for Q1 2020.